Literature DB >> 2619982

The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation.

S R Kay1, L A Opler, J P Lindenmayer.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2619982

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN： 0960-5371


× No keyword cloud information.
  215 in total

1.  Measuring readiness-to-change substance misuse among psychiatric outpatients: I. Reliability and validity of self-report measures.

Authors:  K B Carey; S A Maisto; M P Carey; D M Purnine
Journal:  J Stud Alcohol       Date:  2001-01

2.  Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up.

Authors:  P Pollak; F Tison; O Rascol; A Destée; J J Péré; J M Senard; F Durif; I Bourdeix
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

3.  Rapid smoking may not be aversive in schizophrenia.

Authors:  Jill M Williams; Kunal K Gandhi; Shou-En Lu; Marc L Steinberg; Neal L Benowitz
Journal:  Nicotine Tob Res       Date:  2012-02-07       Impact factor: 4.244

Review 4.  Positive-negative symptom assessment in schizophrenia: psychometric issues and scale comparison.

Authors:  S R Kay
Journal:  Psychiatr Q       Date:  1990

5.  Higher nicotine levels in schizophrenia compared with controls after smoking a single cigarette.

Authors:  Jill M Williams; Kunal K Gandhi; Shou-En Lu; Supriya Kumar; Junwu Shen; Jonathan Foulds; Howard Kipen; Neal L Benowitz
Journal:  Nicotine Tob Res       Date:  2010-06-28       Impact factor: 4.244

Review 6.  Are the available apathy measures reliable and valid? A review of the psychometric evidence.

Authors:  Diana E Clarke; Jean Y Ko; Emily A Kuhl; Robert van Reekum; Rocio Salvador; Robert S Marin
Journal:  J Psychosom Res       Date:  2010-03-31       Impact factor: 3.006

7.  Effects of transcranial direct current stimulation on the auditory mismatch negativity response and working memory performance in schizophrenia: a pilot study.

Authors:  Danielle Impey; Ashley Baddeley; Renee Nelson; Alain Labelle; Verner Knott
Journal:  J Neural Transm (Vienna)       Date:  2017-09-01       Impact factor: 3.575

8.  Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.

Authors:  Jan Volavka; Pál Czobor; Leslie Citrome; Richard A Van Dorn
Journal:  CNS Spectr       Date:  2013-11-28       Impact factor: 3.790

9.  Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation.

Authors:  Daniel P Dickstein; Kenneth E Towbin; Jan Willem Van Der Veen; Brendan A Rich; Melissa A Brotman; Lisa Knopf; Laura Onelio; Daniel S Pine; Ellen Leibenluft
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-02       Impact factor: 2.576

10.  Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study.

Authors:  Deepak C D'Souza; Rajiv Radhakrishnan; Edward Perry; Savita Bhakta; Nagendra M Singh; Richa Yadav; Danielle Abi-Saab; Brian Pittman; Santosh K Chaturvedi; Mahendra P Sharma; Morris Bell; Chittaranjan Andrade
Journal:  Neuropsychopharmacology       Date:  2012-10-24       Impact factor: 7.853
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.